What will HNSCC investments and HR+ shifts mean for NYC trials in flu?
              How do HNSCC investments and HR+ shifts affect NYC flu-season trials? Expect resource reallocation, enrollment seasonality, and special considerations for elderly and treatment-resistant patients—plus practical steps to improve participation.
              
              
                Robert Maxwell
                Oct 20, 2025
              
              
                
                    hormone-positive breast cancer
                    Head and neck SCC
                    Spironolactone trials
                    Gynecologic cancer research